Detection of Chromosomal and Plasmid-Mediated Quinolone Resistance Among Escherichia coli Isolated from Urinary Tract Infection Cases; Zagazig University Hospitals, Egypt

References

• Alanazi MQ, Alqahtani FY, Aleanizy FS. An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study. Ann Clin Microbiol Antimicrob. 2018;17(1):3. doi:10.1186/s12941-018-0255-z29422058
   PubMed Web of Science ®Google Scholar
• Azargun R, Sadeghi MR, Barhaghi MH, et al. The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections. Infect Drug Resist. 2018;11:1007–1014. doi:10.2147/IDR30087570
   PubMed Web of Science ®Google Scholar
• Gajdács M, Ábrók M, Lázár A, Burián K. Comparative epidemiology and resistance trends of common urinary pathogens in a tertiary-care hospital: a 10-year surveillance study. Medicina (Kaunas). 2019;55(7):356.
   PubMed Web of Science ®Google Scholar
• Yekani M, Baghi HB, Sefidan FY, Azargun R, Memar MY, Ghotaslou R. The rates of quinolone, trimethoprim/sulfamethoxazole and aminoglycoside resistance among Enterobacteriaceae isolated from urinary tract infections in Azerbaijan, Iran. GMS Hyg Infect Control. 2018;13:Doc07.30202721
   PubMed Web of Science ®Google Scholar
• Aldred KJ, Kerns RJ, Osheroff N. Mechanism of quinolone action and resistance. Biochemistry. 2014;53(10):1565–1574. doi:10.1021/bi500056424576155
   PubMed Web of Science ®Google Scholar
• Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis. 2005;41(Suppl 2):S120–S126. doi:10.1086/42805215942878
   PubMed Web of Science ®Google Scholar
• Varughese LR, Rajpoot M, Goyal S, Mehra R, Chhokar V, Beniwal V. Analytical profiling of mutations in quinolone resistance determining region of gyrA gene among UPEC. PLoS One. 2018;13(1):e0190729. doi:10.1371/journal.pone.019072929300775
   PubMed Web of Science ®Google Scholar
• Martínez-Martínez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998;351(9105):797–799. doi:10.1016/S0140-6736(97)07322-49519952
   PubMed Web of Science ®Google Scholar
• Xue G, Li J, Feng Y, et al. High prevalence of plasmid-mediated quinolone resistance determinants in Escherichia coli and Klebsiella pneumoniae isolates from pediatric patients in China. Microb Drug Resist. 2017;23(1):107–114. doi:10.1089/mdr.2016.000427167505
   PubMed Web of Science ®Google Scholar
• Nazik H, Bektöre B, Öngen B, et al. Plasmid-mediated quinolone resistance genes in Escherichia coli urinary isolates from two teaching hospitals in Turkey: coexistence of TEM, SHV, CTX-M and VEB-1 type -lactamases. Trop J Pharm Res. 2011;10(3):325–333. doi:10.4314/tjpr.v10i3.9
   Web of Science ®Google Scholar
• Jacoby GA, Strahilevitz J, Hooper DC. Plasmid-mediated quinolone resistance. Microbiol Spectr. 2014;2(5). doi:10.1128/microbiolspec.PLAS-0006-2013
   Google Scholar
• Clinical and Laboratory Standards Institute. M100 Performance Standards for Antimicrobial Susceptibility Testing, 28th ed. CLSI supplement M100 Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Ozeki S, Deguchi T, Yasuda M, et al. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections. J Clin Microbiol. 1997;35(9):2315–2319. doi:10.1128/JCM.35.9.2315-2319.19979276409
   PubMed Web of Science ®Google Scholar
• Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007;60(2):394–397. doi:10.1093/jac/dkm20417561500
   PubMed Web of Science ®Google Scholar
• Le TM, Baker S, Le TP, et al. High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J Med Microbiol. 2009;58(pt12):1585–1592. doi:10.1099/jmm.0.010033-019696153
   PubMed Web of Science ®Google Scholar
• Wareham DW, Umoren I, Khanna P, Gordon NC. Allele-specific polymerase chain reaction (PCR) for rapid detection of the aac (6′)-Ib-cr quinolone resistance gene. Int J Antimicrob Agents. 2010;36(5):476–477. doi:10.1016/j.ijantimicag.2010.07.01220843664
   PubMed Web of Science ®Google Scholar
• Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2015;15:545. doi:10.1186/s12879-015-1282-426607324
   PubMed Web of Science ®Google Scholar
• El-Mahdy RH, Saleh MA, Aboelnour A. GyrA mutations in nosocomial ciprofloxacin-resistant Escherichia coli isolates associated with urinary tract infections. Int J Curr Microbiol App Sci. 2017;6(2):1902–1907. doi:10.20546/ijcmas.2017.602.215
   Google Scholar
• Tandogdu Z, Cek M, Wagenlehner F, et al. Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World J Urol. 2014;32(3):791–801. doi:10.1007/s00345-013-1154-823979151
   PubMed Web of Science ®Google Scholar
• Shenagari M, Bakhtiari M, Mojtahedi A, Roushan ZA. High frequency of mutations in gyrA gene associated with quinolones resistance in uropathogenic Escherichia coli isolates from the north of Iran. Iran J Basic Med Sci. 2018;21(12):1226–1231. doi:10.22038/ijbms.2018.31285.753930627365
   PubMed Web of Science ®Google Scholar
• Muhammad I, Uzma M, Yasmin B, Mehmood Q, Habib B. Prevalence of antimicrobial resistance and integrons in Escherichia coli from Punjab, Pakistan. Braz J Microbiol. 2011;42(2):462–466. doi:10.1590/S1517-8382201100020000824031655
   PubMed Web of Science ®Google Scholar
• Sotto A, De Boever CM, Fabbro-Peray P, Gouby A, Sirot D, Jourdan J. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study. J Clin Microbiol. 2001;39(2):438–444. doi:10.1128/JCM.39.2.438-444.200111158087
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Hoban DJ, DeCorby MR, Laing NM, Zhanel GG. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob Agents Chemother. 2006;50(6):2251–2254. doi:10.1128/AAC.00123-0616723598
   PubMed Web of Science ®Google Scholar
• Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res. 2014;139(6):945–948.25109731
   PubMed Web of Science ®Google Scholar
• Majlesi A, Kakhki RK, Nejad ASM, et al. Detection of plasmid-mediated quinolone resistance in clinical isolates of Enterobacteriaceae strains in Hamadan, West of Iran. Saudi J Biol Sci. 2018;25(3):426–430. doi:10.1016/j.sjbs.2016.11.01929686506
   PubMed Web of Science ®Google Scholar
• Minarini LA, Darini AL. Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from Brazil. Braz J Microbiol. 2012;43(4):1309–1314. doi:10.1590/S1517-8382201200040001024031957
   PubMed Web of Science ®Google Scholar
• Lindgren PK, Karlsson Å, Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother. 2003;47(10):3222–3232. doi:10.1128/AAC.47.10.3222-3232.200314506034
   PubMed Web of Science ®Google Scholar
• van der Starre WE, van Nieuwkoop C, Paltansing S, et al. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother. 2011;66(3):650–656. doi:10.1093/jac/dkq46521123286
   PubMed Web of Science ®Google Scholar
• Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother. 2005;49(1):118–125. doi:10.1128/AAC.49.1.118-125.200515616284
   PubMed Web of Science ®Google Scholar
• El-sayed Marei Y, Mohamed Aboul-Ola O, Zakaria El-Azab S, Mohammad Kishk R, Mohammad Fouad M. Detection of plasmid-mediated quinolone resistance determinants in ESBLs and non-ESBLs producing Enterobacteriaceae from urinary tract infections. Ann Clin Immunol Microbiol. 2019;1(2):1008.
   Google Scholar
• Khalil M, Elsherif R, Ghaith D, et al. Quinolone resistance detection by PCR-RFLP and multiplex-PCR among extended- spectrum β- lactamase producing Enterobacteriaceae. Int J Clin Med Microbiol. 2017;2:119. doi:10.15344/2456-4028/2017/119
   Google Scholar
• Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003;47(7):2242–2248. doi:10.1128/AAC.47.7.2242-2248.200312821475
   PubMed Web of Science ®Google Scholar
• Jeong J-Y, Yoon HJ, Kim ES, et al. Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob Agents Chemother. 2005;49(6):2522–2524. doi:10.1128/AAC.49.6.2522-2524.200515917562
   PubMed Web of Science ®Google Scholar
• Kao CY, Wu HM, Lin WH, et al. Plasmid-mediated quinolone resistance determinants in quinolone-resistant Escherichia coli isolated from patients with bacteremia in a university hospital in Taiwan, 2001–2015. Sci Rep. 2016;6:32281. doi:10.1038/srep3228127573927
   PubMed Web of Science ®Google Scholar
• Akya A, Lorestani RC, Elahi A, Ghadiri K. The impact of mutations in topoisomerase genes and the plasmid-mediated quinolone resistance (PMQR) determinants on the resistance to fluoroquinolones in Klebsiella pneumoniae. Arch Clin Infect Dis. 2017;14(4):e57290.
   Google Scholar
• Robicsek A, Strahilevitz J, Jacoby GA, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006;12(1):83. doi:10.1038/nm134716369542
   PubMed Web of Science ®Google Scholar
• Heisig P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother. 1996;40(4):879–885. doi:10.1128/AAC.40.4.8798849244
   PubMed Web of Science ®Google Scholar
• Lindbäck E, Rahman M, Jalal S, Wretlind B. Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae. APMIS. 2002;110(9):651–657. doi:10.1034/j.1600-0463.2002.1100909.x12529019
   PubMed Web of Science ®Google Scholar
• Hu FP, Xu XG, Zhu DM, Wang MG. Coexistence of qnrB4 and qnrS1 in a clinical strain of Klebsiella pneumoniae. Acta Pharmacol Sin. 2008;29(3):320–324. doi:10.1111/j.1745-7254.2008.00757.x18298896
   PubMed Web of Science ®Google Scholar